Quick-Glia™ Microglia – Maintenance Medium
Quick-Glia™ Microglia – Maintenance Medium is formulated for long-term maintenance of human iPSC- and ESC-derived microglia in vitro. Designed for research use, this medium supports consistent culture performance for downstream experimental applications.
$320.00
Product Specifications
| Parameters | Specifications |
|---|---|
| Product Name | Quick-Glia™ Microglia - Maintenance Medium |
| Catalog No. | MG-MM |
| Product Components | Component MG1, Component MG2, and Component MG3 |
| Storage Conditions | All components can be stored at -20°C or -80°C. |
| Cell Type | Microglia |
| Shelf Life | 1 Year |
| Sterility | No growth observed for Bacteria and Fungus |
| Mycoplasma | No contamination detected |
| Restricted Use | For research use only. Not for use in diagnostic or therapeutic procedures. |
Microglia Resources
Generation of a Collection of CNS Cells from iPSCs by Quick-Tissue™ Technology
2026 Product Catalog
High-Throughput Screening of FDA-Approved Compounds Identifies Modulators of Phagocytic Activity in iPSC-Derived Microglia (SfN 2025)
Patient-Derived iPSC Neuronal Models Reveal Alzheimer’s Disease-Associated Pathology and Provide a Platform for Drug Discovery (SfN 2025)
Quick-Glia™ Microglia – Maintenance Medium
No results found.
Related Products
FAQs
What applications are iPSC-derived microglia used for?
Human iPSC-derived microglia are widely used in applications including neuroinflammation research, neurodegenerative disease modeling, drug discovery, toxicity screening, and microglia–neuron or microglia–astrocyte co-culture systems. Their reproducibility and human relevance make them well suited for both academic and translational research.
Are these off-the-shelf microglia ready to use after thawing?
Yes. Quick-Glia™ human iPSC-derived microglia are cryopreserved and delivered as off-the-shelf microglia that can be thawed and plated directly into culture. The cells mature rapidly post-thaw and are ready for functional assays within approximately one week, streamlining experimental timelines.
How do iPSC-derived microglia compare to primary microglia?
Compared to primary microglia, iPSC-derived microglia offer greater consistency, scalability, and experimental reproducibility. While primary microglia are limited by donor variability and availability, human iPSC-derived microglia provide an off-the-shelf alternative that enables standardized assays, repeatable workflows, and reliable data generation across experiments.
What are iPSC-derived microglia?
iPSC-derived microglia are human microglial cells generated from induced pluripotent stem cells (iPSCs). These cells recapitulate key molecular, morphological, and functional characteristics of human microglia, making them a powerful in vitro model for studying microglial biology, neuroinflammation, and neurodegenerative disease.
No results found.